137 related articles for article (PubMed ID: 2648096)
1. Differential effect of N-ethoxycarbonyl-2-ethoxy-1,2-dihydroquinoline (EEDQ) on [3H]SCH23390 and [3H]forskolin binding in rat striatum.
Norman AB; Wachendorf TJ; Sanberg PR
Life Sci; 1989; 44(13):831-6. PubMed ID: 2648096
[TBL] [Abstract][Full Text] [Related]
2. Differential modification of striatal D1 dopamine receptors and effector moieties by N-ethoxycarbonyl-2-ethoxy-1,2-dihydroquinoline in vivo and in vitro.
Hess EJ; Battaglia G; Norman AB; Creese I
Mol Pharmacol; 1987 Jan; 31(1):50-7. PubMed ID: 3100940
[TBL] [Abstract][Full Text] [Related]
3. In vivo partial inactivation of dopamine D1 receptors induces hypersensitivity of cortical dopamine-sensitive adenylate cyclase: permissive role of alpha 1-adrenergic receptors.
Trovero F; Hervé D; Blanc G; Glowinski J; Tassin JP
J Neurochem; 1992 Jul; 59(1):331-7. PubMed ID: 1351927
[TBL] [Abstract][Full Text] [Related]
4. Forskolin potentiates the stimulation of rat striatal adenylate cyclase mediated by D-1 dopamine receptors, guanine nucleotides, and sodium fluoride.
Battaglia G; Norman AB; Hess EJ; Creese I
J Neurochem; 1986 Apr; 46(4):1180-5. PubMed ID: 3005508
[TBL] [Abstract][Full Text] [Related]
5. Binding of [3H]forskolin to human platelet membranes. Regulation by guanyl-5'-yl imidodiphosphate, NaF, and prostaglandins E1 and D2.
Nelson CA; Seamon KB
J Biol Chem; 1986 Oct; 261(29):13469-73. PubMed ID: 3463564
[TBL] [Abstract][Full Text] [Related]
6. Functional recovery of D1 dopamine receptor-mediated stimulation of rat striatal adenylate cyclase activity following irreversible receptor modification by N-ethoxycarbonyl-2-ethoxy-1,2-dihydroquinoline (EEDQ): evidence for spare receptors.
Battaglia G; Norman AB; Hess EJ; Creese I
Neurosci Lett; 1986 Sep; 69(3):290-5. PubMed ID: 2945128
[TBL] [Abstract][Full Text] [Related]
7. Regional modulation of [3H]forskolin binding in the rat brain by guanylyl-5'-imidodiphosphate and sodium fluoride: comparison with the distribution of guanine nucleotide binding sites.
Gehlert DR
J Pharmacol Exp Ther; 1986 Dec; 239(3):952-8. PubMed ID: 3795054
[TBL] [Abstract][Full Text] [Related]
8. Selective unilateral inactivation of striatal D1 and D2 dopamine receptor subtypes by EEDQ: turning behavior elicited by D2 dopamine receptor agonists.
Giorgi O; Biggio G
Brain Res; 1990 Nov; 533(1):53-9. PubMed ID: 1982234
[TBL] [Abstract][Full Text] [Related]
9. Chronic treatment with dopamine receptor antagonists: behavioral and pharmacologic effects on D1 and D2 dopamine receptors.
Hess EJ; Norman AB; Creese I
J Neurosci; 1988 Jul; 8(7):2361-70. PubMed ID: 2907912
[TBL] [Abstract][Full Text] [Related]
10. Guanine nucleotide regulation of agonist interactions at [3H]SCH23390-labeled D1 dopamine receptors in rat striatum.
Hess EJ; Battaglia G; Norman AB; Iorio LC; Creese I
Eur J Pharmacol; 1986 Feb; 121(1):31-8. PubMed ID: 2869957
[TBL] [Abstract][Full Text] [Related]
11. Rate of recovery of D1 and D2 dopaminergic receptors in young vs. adult rat striatal tissue following alkylation with ethoxycarbonyl-ethoxy-dihydroquinoline (EEDQ).
Kula NS; George T; Baldessarini RJ
Brain Res Dev Brain Res; 1992 Apr; 66(2):286-9. PubMed ID: 1535031
[TBL] [Abstract][Full Text] [Related]
12. Effects of in vivo and in vitro treatments with N-ethoxycarbonyl-2-ethoxy-1,2-dihydroquinoline on putative muscarinic receptor subtypes in rat brain.
Norman AB; Creese I
Mol Pharmacol; 1986 Aug; 30(2):96-103. PubMed ID: 3755499
[TBL] [Abstract][Full Text] [Related]
13. Effects of sodium, lithium, and magnesium on in vitro binding of [3H]SCH23390 in rat neostriatum and cerebral cortex.
Gottberg E; Diop L; Montreuil B; Reader TA
Neurochem Res; 1989 May; 14(5):419-26. PubMed ID: 2526301
[TBL] [Abstract][Full Text] [Related]
14. Acute in vivo amphetamine produces a homologous desensitization of dopamine receptor-coupled adenylate cyclase activities and decreases agonist binding to the D1 site.
Roseboom PH; Gnegy ME
Mol Pharmacol; 1989 Jan; 35(1):139-47. PubMed ID: 2563306
[TBL] [Abstract][Full Text] [Related]
15. Dopaminergic behaviors and signal transduction mediated through adenylate cyclase and phospholipase C pathways.
Undie AS; Berki AC; Beardsley K
Neuropharmacology; 2000; 39(1):75-87. PubMed ID: 10665821
[TBL] [Abstract][Full Text] [Related]
16. Effect of aging on recovery of striatal dopamine receptors following N-ethoxycarbonyl-2-ethoxy-1, 2-dihydroquinoline (EEDQ) blockade.
Henry JM; Roth GS
Life Sci; 1984 Aug; 35(8):899-904. PubMed ID: 6482680
[TBL] [Abstract][Full Text] [Related]
17. Binding sites for [3H]SCH 23390 in retina: properties and possible relationship to dopamine D1-receptors mediating stimulation of adenylate cyclase.
Makman MH; Dvorkin B
Brain Res; 1986 Dec; 387(3):261-70. PubMed ID: 2950967
[TBL] [Abstract][Full Text] [Related]
18. Characterization of [3H]forskolin binding sites in the iris-ciliary body of the albino rabbit.
Goldman ME; Mallorga P; Pettibone DJ; Sugrue MF
Life Sci; 1988; 42(13):1307-14. PubMed ID: 3352456
[TBL] [Abstract][Full Text] [Related]
19. Effects of chronic SCH23390 treatment on the biochemical and behavioral properties of D1 and D2 dopamine receptors: potentiated behavioral responses to a D2 dopamine agonist after selective D1 dopamine receptor upregulation.
Hess EJ; Albers LJ; Le H; Creese I
J Pharmacol Exp Ther; 1986 Sep; 238(3):846-54. PubMed ID: 3018223
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of [3H]forskolin binding by Gpp[NH]p may reflect adenylate cyclase coupling to Gi.
Garcia-Jiménez A; Cowburn RF; Winblad B; Fastbom J
Neuroreport; 1999 Aug; 10(11):2423-7. PubMed ID: 10439475
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]